Phenotypic and genotypic characterization of resistance to third-generation cephalosporins in Enterobacter spp.;Caracterización fenotípica y genotípica de la resistencia enzimática a las cefalosporinas de tercera generación en Enterobacter spp.

Revista Argentina de Microbiologia

Volumn 37, Issue 4, 2005, Pages 203-208

  Bertona, E ^a   Radice, M ^b   Rodriguez C H ^c   Barberis, C ^c   Vay, C ^c   Famiglietti, A ^c   Gutkind, G ^b  

^a Escuela de Graduados   (Peru)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Cefepime; Enterobacter spp.; Expanded spectrum lactamases

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE AMPC; CEFALOTIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; DIAGNOSTIC TEST; DIFFUSION SYNERGY TEST; ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; GENOTYPE; HOSPITAL INFECTION; INHIBITION KINETICS; NONHUMAN; PHENOTYPE;

BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; GENOTYPE; HUMANS; ISOELECTRIC POINT; MICROBIAL SENSITIVITY TESTS; PHENOTYPE;

EID: 31944444985     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Abbot S (1999) Klebsiella, Enterobacter, Citrobacter, and Berratia. En: Murray P, Baron E, Pfaller M, Tenover F, Yolken (Ed), Manual of Clinical Microbiology. 7th edition. ASM Press, Washington, Estados Unidos de America, p. 475-482.
2. Bantar C, Famiglietti A, Goldberg M, Committee TA, Group. TNSPSP (2000) Three-year surveillance study of nosocomial bacterial resistance in Argentina. Int. J. Infect. Dis. 4: 85-90.
3. PER-2 which encodes an extended-spectrum class A β-lactamase. Antimicrob Agents Chemother. 40: 616-620.
4. Bauernfeind A, Stemplinger Y, Jungwirth R, Ernst S, Casellas JM (1996) Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases. Antimicrob. Agents Chemother. 40: 509-513.
5. st century: Characterization, epidemiology and detection of this important resistance threat. Clin. Microbiol. Rev. 14: 933-951.
6. Famiglietti A, Quinteros M, Vázquez M, Marín M, Nicola F, Radice M, et al. (2005) Consenso sobre las pruebas de sensibilidad a los antimicrobianos en Enterobacteriaceae. Rev. Argent. Microbiol. 37: 57-66.
7. Galas M, Rapoport M, Pasterán F, Melano R, Petroni A, Ceriana P, et al. (1999) High distribution of CTX-M-2 beta-lactamases among Klesiella spp. isolates in argentinean extended-spectrum beta-lactamase (esbla) surveillance program. 39 th. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICCAC) Abstract 1474, pag. 165, San Francisco, California, USA.
8. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10: 867-878.
9. Livermore DM (1995) β-lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8: 557-584.
10. Matthew M, Harris AM, Marshall MJ, Ross GW (1975) The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. General Microbiol. 88: 169-178.
11. National Committee for Clinical Laboratory Standards (2004) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Sixth edition, Approved standard, Wayne, Pa., Estados Unidos de America.
12. National Committee for Clinical Laboratory Standards (2004) Performance standards for antimicrobial disk susceptibility tests. Eight edition, Approved standard, Wayne, Pa., Estados Unidos de América.
13. Pasteran F, Melano R, Galas M (1999) High proportion of extended spectrum beta-lactamases (esbla) among Amp-C producers enterobacteria in Argentina. 39 th. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICCAC) Abstract 1475, p. 166, San Francisco, California, USA.
14. Power P, Radice M, Barberis C, de Mier C, Mollerach M, Maltagliatti M, et al. (1999) Cefotaxime-hydrolysing β-lactamases in Morganella morganii. Eur. J. Clin. Microbiol. Infect. Dis. 18: 743-747.
15. Quinteros M, Radice M, Gardella N, Rodriguez MM, Costa N, Korbenfeld D, et al. (2003) Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob. Agents Chemother. 47: 2864-2869.
16. Quinteros M, Radice M, Power P, Matteo M, Mollerach M, Conza JD, et al. (1999) Detection of extended-spectrum β-lactamases in microorganisms harboring an AmpC β-lactamase. International Congress on β-Lactamases, Abstract A27, L'Aquila, ltalia.
17. Rodriguez C, Juárez J, de Mier C, Pugliese L, Blanco G, Vay C, et al. (2003) Resistencia a antibioticos en gram negativos aislados en unidades de cuidados intensivos. Análisis comparativo de dos períodes (1998-2001) Medicina. 63: 21-27.
18. Rossi A, Lopardo H, Woloj M, Picandet AM, Marino M, Galas M, et al. (1995) Non-typhoid Salmonella spp. resistant to cefotaxime. J. Antimicrob. Chemother. 36: 697-702.
19. Sanders E, Sanders C (1997) Enterobacter. a pathogen poised to flourish at the turn of the century. Clin. Microbiol. Rev. 10: 220-241
20. Soussy C, Carret G, Cavallo J-D, Chardon H, Chidiac C (2000) Antibiogram committee of the french microbiology society. Report 2000-2001. Pathol. Biol. 48: 832-871.
21. Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A (2000) Detection of extended-spectrum β-lac-tamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J. Clin. Microbiol. 38: 542-546.